<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT01295463</url>
  </required_header>
  <id_info>
    <org_study_id>ICO-FERTI</org_study_id>
    <secondary_id>CDR0000695000</secondary_id>
    <secondary_id>EU-21105</secondary_id>
    <nct_id>NCT01295463</nct_id>
  </id_info>
  <brief_title>Study of Information Received About Fertility and Infertility in Patients Who Have Finished Treatment for Cancer</brief_title>
  <official_title>Descriptive Study to Evaluate the Information and Psychosocial Issues on the Risk on Infertility in Cancer Patients After Receiving Treatment in a Comprehensive Cancer Center</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Institut Català d'Oncologia</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>National Cancer Institute (NCI)</source>
  <brief_summary>
    <textblock>
      RATIONALE: Learning about the amount of information on fertility and infertility by patients
      before they received treatment for cancer in a comprehensive cancer center may help doctors
      plan the best treatment.

      PURPOSE: This clinical trial is studying the amount of information on fertility and
      infertility received by patients before treatment of cancer in patients who have finished
      treatment.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      OBJECTIVES:

      Primary

        -  To determine the amount of information received on aspects of fertility and infertility
           in patients with cancer prior to receiving treatment in a comprehensive cancer center.

      Secondary

        -  To analyze whether the information received by patients is related to the desire to be
           parents.

        -  To analyze whether the information received by patients is related to the desire to be
           informed.

        -  To determine whether there is a relationship between demographic data, diagnosis,
           quality of life, and associated psychosocial information received by patients.

      OUTLINE: Patients complete questionnaires (Lickert and QLQ-C30) on the amount of information
      received prior to therapy and psychosocial issues on aspects of fertility and infertility
      once within 1-2 years after receiving treatment.
    </textblock>
  </detailed_description>
  <overall_status>Unknown status</overall_status>
  <last_known_status>Recruiting</last_known_status>
  <start_date>December 2010</start_date>
  <primary_completion_date type="Anticipated">June 2012</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <primary_outcome>
    <measure>Amount of information received on aspects of fertility and infertility</measure>
  </primary_outcome>
  <primary_outcome>
    <measure>Relationship between demographic data, diagnosis, quality of life, and associated psychosocial information received</measure>
  </primary_outcome>
  <enrollment type="Anticipated">96</enrollment>
  <condition>Cancer</condition>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>questionnaire administration</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Other</intervention_type>
    <intervention_name>study of socioeconomic and demographic variables</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>assessment of therapy complications</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>fertility assessment and management</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>psychosocial assessment and care</intervention_name>
  </intervention>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>quality-of-life assessment</intervention_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        DISEASE CHARACTERISTICS:

          -  Diagnosis of breast cancer, germ cell tumor, colon cancer, leukemia, lymphoma, or
             sarcoma

               -  Free of disease

          -  Completed treatment within the past 1-2 years

        PATIENT CHARACTERISTICS:

          -  ECOG performance status 0-1

          -  Must be able to read and self-complete study questionnaires

          -  No psychological conditions that may prevent participation in the study

        PRIOR CONCURRENT THERAPY:

          -  See Disease Characteristics

          -  No concurrent treatment (hormonal treatment for breast cancer is allowed)
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Josefina Rivera, RGN, MSN</last_name>
    <role>Principal Investigator</role>
    <affiliation>Institut Català d'Oncologia</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Institut Catala D'Oncologia</name>
      <address>
        <city>l'Hospitalet de Llobregat</city>
        <zip>08907</zip>
        <country>Spain</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Josefina Rivera, RGN, MSN</last_name>
      <phone>34-93-260-7332</phone>
      <email>jrivera@iconcologia.net</email>
    </contact>
  </location>
  <location_countries>
    <country>Spain</country>
  </location_countries>
  <verification_date>February 2011</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>February 11, 2011</study_first_submitted>
  <study_first_submitted_qc>February 11, 2011</study_first_submitted_qc>
  <study_first_posted type="Estimate">February 14, 2011</study_first_posted>
  <last_update_submitted>August 9, 2013</last_update_submitted>
  <last_update_submitted_qc>August 9, 2013</last_update_submitted_qc>
  <last_update_posted type="Estimate">August 12, 2013</last_update_posted>
  <keyword>sexual dysfunction</keyword>
  <keyword>psychosocial effects of cancer and its treatment</keyword>
  <keyword>infertility</keyword>
  <keyword>colon cancer</keyword>
  <keyword>male breast cancer</keyword>
  <keyword>breast cancer</keyword>
  <keyword>germ cell tumor</keyword>
  <keyword>ovarian sarcoma</keyword>
  <keyword>uterine sarcoma</keyword>
  <keyword>chronic lymphocytic leukemia</keyword>
  <keyword>osteosarcoma</keyword>
  <keyword>chronic myelogenous leukemia</keyword>
  <keyword>non-Hodgkin lymphoma</keyword>
  <keyword>adult acute myeloid leukemia with 11q23 (MLL) abnormalities</keyword>
  <keyword>adult acute myeloid leukemia with inv(16)(p13;q22)</keyword>
  <keyword>adult acute myeloid leukemia with t(15;17)(q22;q12)</keyword>
  <keyword>adult acute myeloid leukemia with t(16;16)(p13;q22)</keyword>
  <keyword>adult acute myeloid leukemia with t(8;21)(q22;q22)</keyword>
  <keyword>mast cell leukemia</keyword>
  <keyword>hairy cell leukemia</keyword>
  <keyword>prolymphocytic leukemia</keyword>
  <keyword>adult acute lymphoblastic leukemia</keyword>
  <keyword>adult acute myeloid leukemia</keyword>
  <keyword>adult Hodgkin lymphoma</keyword>
  <keyword>adult T-cell leukemia/lymphoma</keyword>
  <keyword>small intestine lymphoma</keyword>
  <keyword>anaplastic large cell lymphoma</keyword>
  <keyword>angioimmunoblastic T-cell lymphoma</keyword>
  <keyword>mycosis fungoides/Sezary syndrome</keyword>
  <keyword>intraocular lymphoma</keyword>
  <keyword>primary central nervous system non-Hodgkin lymphoma</keyword>
  <keyword>primary central nervous system Hodgkin lymphoma</keyword>
  <keyword>noncutaneous extranodal lymphoma</keyword>
  <keyword>secondary acute myeloid leukemia</keyword>
  <keyword>acute undifferentiated leukemia</keyword>
  <keyword>central nervous system leukemia</keyword>
  <keyword>T-cell large granular lymphocyte leukemia</keyword>
  <keyword>atypical chronic myeloid leukemia, BCR-ABL1 negative</keyword>
  <keyword>clear cell sarcoma of the kidney</keyword>
  <keyword>Kaposi sarcoma</keyword>
  <keyword>adult soft tissue sarcoma</keyword>
  <keyword>chronic myelomonocytic leukemia</keyword>
  <keyword>secondary central nervous system Hodgkin lymphoma</keyword>
  <keyword>cutaneous lymphoma</keyword>
  <keyword>adult non-Hodgkin lymphoma</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Infertility</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

